Significance of platelet count in esophageal carcinomas

Saudi Journal of Gastroenterology

Volumn 17, Issue 2, 2011, Pages 134-137

  Aminian, Ali ^a,b   Karimian, Faramarz ^a   Mirsharifi, Rasoul ^a   Alibakhshi, Abbas ^a   Dashti, Habibollah ^a   Jahangiri, Yosra ^a   Safari, Saeed ^a   Ghaderi, Hamid ^a   Noaparast, Morteza ^a   Hasani, Sharareh M ^a   Mirsharifi, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; esophagus; platelet; prognosis; thrombocytosis

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; DISTANT METASTASIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOCYTOSIS;

EID: 79952983926     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.77245     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005;55:74-108.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50. (Pubitemid 46655601)
3. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in tehran metropolis: The first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med 2009;12:15-23.
4. Alibakhshi A, Aminian A, Mirsharifi R, Jahangiri Y, Dashti H, Karimian F. The effect of age on the outcome of esophageal cancer surgery. Ann Thorac Med 2009;4:71-4.
5. Aminian A, Mirsharifi R, Karimian F, Khorgami Z, Nasiri S, Yazdankhah A, et al. Influence of splenectomy on morbidity of esophageal cancer surgery. Scand J Surg 2010;99:9-13.
6. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C, et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 2000;21:309-14. (Pubitemid 30666035)
7. Symbas NP, Townsend MF, El-Galley R, Keane TE, Graham SD, Petros JA. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 2000;86:203-7. (Pubitemid 30621216)
8. Monreal M, Fernandez-Llamazares J, Pinol M, Julian JF, Broggi M, Escola D, et al. Platelet count and survival in patients with colorectal cancer: A preliminary study. Thromb Haemost 1998;79:916-8. (Pubitemid 28224723)
9. Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, et al. Survival of patients in a Phase 1 Clinic: The M. D. Anderson Cancer Center experience. Cancer 2009;115:1091-9.
10. Gerestein CG, Eijkemans MJ, de Jong D, van der Burg ME, Dykgraaf RH, Kooi GS, et al. The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG 2009;116:372-80.
11. Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 2004;198:737-41. (Pubitemid 38542902)
12. Griffiths L, Stratford IJ. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumor growth and response to therapy. Br J Cancer 1997;76:689-93. (Pubitemid 27379732)
13. Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, et al. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 1998;253:797-803. (Pubitemid 29039222)
14. Shimada H, Takeda A, Shiratori T, Nabeya Y, Okazumi S, Matsubara H, et al. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer 2002;94:1947-54. (Pubitemid 34270047)
15. Kitadai Y, Onogawa S, Kuwai T, Matsumura S, Hamada H, Ito M, et al. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 2004;11:315-9.
16. Takebayashi Y, Natsugoe S, Baba M, Akiba S, Fukumoto T, Miyadera K, et al. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 1999;85:282-9. (Pubitemid 29051280)
17. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998;82:1225-32. (Pubitemid 28155382)
18. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, et al. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 1999;59:1911-6. (Pubitemid 29186165)
19. Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, Burney I, et al. Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol 2004;15:118-22. (Pubitemid 38139612)
20. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M, et al. Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas. Eur Surg Res 1999;31:357-63. (Pubitemid 29381172)